Effects of treatment with the atypical neuroleptic quetiapine on working memory function: A functional MRI follow-up investigation

European Archives of Psychiatry and Clinical Neuroscience

Volumn 256, Issue 8, 2006, Pages 522-531

  Meisenzahl, E M ^a   Scheuerecker, J ^a   Zipse, M ^a   Ufer, S ^a   Wiesmann, M ^a   Frodl, T ^a   Koutsouleris, N ^a   Zetzsche, T ^a   Schmitt, G ^a   Riedel, M ^a   Spellmann, I ^a   Dehning, S ^a   Linn, J ^a   Bruckmann H ^a   Moller H J ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Functional magnetic resonance imaging; Neuroleptic treatment; Quetiapine; Schizophrenia; Working memory

Indexed keywords

QUETIAPINE;

ARTICLE; BASAL GANGLION; BEHAVIOR; BRAIN DEPTH STIMULATION; CAUDATE NUCLEUS; DRUG EFFICACY; FOLLOW UP; FRONTAL LOBE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; MEASUREMENT ERROR; NERVE CELL NETWORK; PREFRONTAL CORTEX; PRIORITY JOURNAL; PSYCHOLOGIC TEST; REACTION TIME; SCHIZOPHRENIA; WORKING MEMORY;

ADULT; ANTIPSYCHOTIC AGENTS; BASAL GANGLIA; CEREBELLUM; CEREBRAL CORTEX; DIBENZOTHIAZEPINES; DISCRIMINATION LEARNING; DOMINANCE, CEREBRAL; FEMALE; FRONTAL LOBE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; MALE; MEMORY, SHORT-TERM; MIDDLE AGED; NERVE NET; OXYGEN; PATTERN RECOGNITION, VISUAL; PREFRONTAL CORTEX; REACTION TIME; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TREATMENT OUTCOME;

EID: 33845884301     PISSN: 09401334     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00406-006-0687-x     Document Type: Article

References (42)

1. Andreasen NC (1989) The Scale for the Assessment of Negative Symptoms (SANS): conceptual and theoretical foundations. Br J Psychiatry 162(7):49-58
2. Arvanitis LA, Miller BG (1997) Multiple fixed doses of "Seroquel" (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. The Seroquel trial 13 study group. Biol Psychiatry 42(4):233-246
3. Barch DM, Braver TS, Nystrom LE, Forman SD, Noll DC, Cohen JD (1997) Dissociating working memory from task difficulty in human prefrontal cortex. Neuropsychologia 35(10):1373-1380
4. Barch DM, Carter CS, Braver TS, Sabb FW, MacDonald A 3rd, Noll DC, Cohen JD (2001) Selective deficits in prefrontal cortex function in medication-naive patients with schizophrenia. Arch Gen Psychiatry 58(3):280-288
5. Bertolino A, Blasi G, Caforio G, Latorre V, De Candia M, Rubino V, Callicott JH, Mattay VS, Bellomo A, Scarabino T, Weinberger DR, Nardini M (2004) Functional lateralization of the sensorimotor cortex in patients with schizophrenia: effects of treatment with olanzapine. Biol Psychiatry 56(3):190-197
6. Buchsbaum MS, Haier RJ, Potkin SG, Nuechterlein K, Bracha HS, Katz M, Lohr J, Wu J, Lottenberg S, Jerabek PA, Trenary M, Tafalla R, Reynolds C, Bunney WE Jr (1992) Frontostriatal disorder of cerebral metabolism in never-medicated schizophrenics. Arch Gen Psychiatry 49:935-942
7. Brett M, Penny WD, Kiebel SJ (2003) Introduction to random field theory. In: Frackowiak RSJ, Friston KJ, Frith C, Dolan R, Friston KJ, Price CJ, Zeki S, Ashburner J, Penny WD (eds) Human brain function, 2nd edn. Academic Press
8. Callicott JH, Mattay VS, Bertolino A, Finn K, Coppola R, Frank JA, Goldberg TE, Weinberger DR (1999) Physiological characteristics of capacity constraints in working memory as revealed by functional MRI. Cereb Cortex 9(1):20-26
9. Callicott JH, Bertolino A, Mattay VS, Langheim FJ, Duyn J, Coppola R, Goldberg TE, Weinberger DR (2000) Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia. Cereb Cortex 10(11):1078-1092
10. Callicott JH, Mattay VS, Verchinski BA, Marenco S, Egan MF, Weinberger DR (2003) Complexity of prefrontal cortical dysfunction in schizophrenia: more than up or down. Am J Psychiatry 160(12):2209-2215
11. Chaudhury IB, Soni SD, Hellewell JSE, Deakin JWF (1997) Antisaccade, clinical and motor executive function in schizophrenia: effects of 5HT2 antagonist, cyproheptadine. Schizophre Res 112(24):212
12. Cuesta MJ, Peralta V, Zarzuela A (2001) Effects of olanzapine and other antipsychotics on cognitive function in chronic schizophrenia: a longitudinal study. Schizophr Res 48(1):17-28
13. D'Esposito M, Postle BR, Rypma B (2000) Prefrontal cortical contributions to working memory: evidence from event-related fMRI studies. Exp Brain Res 133(1):3-11
14. Erkwoh R, Sabri O, Schreckenberger M, Setani K, Aßfalg S, Sturz L, Fehler S, Pleßmann S (2002) Cerebral correlates of selective attention in schizophrenic patients with formal thought disorder: a controlled H215O-PET study. Psychiatry Res Neuroimaging 15(115):137-153
15. Fahim C, Stip E, Mancini-Marie A, Gendron A, Mensour B, Beauregard M (2005) Differential hemodynamic brain activity in schizophrenia patients with blunted affect during quetiapine treatment. J Clin Psychopharmacol 25(4):367-371
16. Good MF, Kiss I, Buiteman C, Woodley H, Ruui Q, Whitehorn D, Kopala L (2002) Improvement in cognitive functioning in patients with first-episode psychosis during treatment with quetiapine: an interim analysis. Br J Psychiatry 43:45-49
17. Goldman-Rakic PS (1994) Working memory dysfunction in schizophrenia. J Neuropsychiatry Clin Neurosci 6(4):348-357
18. Honey GD, Bullmore ET, Soni W, Varatheesan M, Williams SC, Sharma T (1999) Differences in frontal cortical activation by a working memory task after substitution of risperidone for typical antipsychotic drugs in patients with schizophrenia. Proc Natl Acad Sci 96(23):13432-13437
19. Jones HM, Brammer MJ, O'Toole M, Taylor T, Ohlsen RI, Brown RG, Purvis R, Williams S, Pilowsky LS (2004) Cortical effects of quetiapine in first-episode schizophrenia: a preliminary functional magnetic resonance imaging study. Biol Psychiatry 56:938-942
20. Kindermann SS, Brown GG, Zorrilla LE, Olsen RK, Jeste DV (2004) Spatial working memory among middle-aged and older patients with schizophrenia and volunteers using fMRI. Schizophr Res 68(2-3):203-216
21. Manoach DS, Press DZ, Thangaraj V, Searl MM, Goff DC, Halpern E, Saper CB, Warach S (1999) Schizophrenic subjects activate dorsolateral prefrontal cortex during a working memory task, as measured by fMRI. Biol Psychiatry 45(9): 1128-1137
22. Manoach DS, Gollub RL, Benson ES, Searl MM, Goff DC, Halpern E, Saper CB, Rauch SL (2000) Schizophrenic subjects show aberrant fMRI activation of dorsolateral prefrontal cortex and basal ganglia during working memory performance. Biol Psychiatry. 15, 48(2):99-109
23. Menon RS (2001) Imaging function in the working brain with fMRI. Curr Opin Neurobiol 11(5):630-636
24. Möller HJ (1999a) Atypical neuroleptics: a new approach in the treatment of negative symptoms. Eur Arch Psychiatry Clin Neurosci 249(4):99-107
25. Möller HJ (1999b) Can negative symptoms of schizophrenia be partially or totally controlled by antipsychotics? Eur Neuropsychopharmacol 9(5):135-136
26. Möller HJ (2000) Results and methodological problems in the evaluation of newer atypical neuroleptics in the treatment of schizophrenic negative symptoms. Nervenarzt (71):345-353
27. Mortimer AM, Dye S (1997) Remediation of neuropsychological impairments with clozapine. Schizophr Res 24:187
28. Perlstein WM, Dixit NK, Carter CS, Noll DC, Cohen JD (2003) Prefrontal cortex dysfunction mediates deficits in working memory and prepotent responding in schizophrenia. Biol Psychiatry 53(1):25-38
29. Petrides M (2000) Dissociable roles of mid-dorsolateral prefrontal and anterior inferotemporal cortex in visual working memory. J Neurosci 20(19):7496-7503
30. Purdon SE (2000) Measuring neuropsychological change in schizophrenia with novel antipsychotic medications. J Psychiatry Neurosci 25(2):108-116
31. Purdon SE, Malla A, Labelle A, Lit W (2001) Neuropsychological change in patients with schizophrenia after treatment with quetiapine or haloperidol. J Psychiatry Neurosci 26(2):137-149
32. Riedel M, Müller N, Strassnig M, Spellmann I, Engel RR, Musil R, Dehning S, Douhet A, Schwarz MJ, Müller HJ (2005) Quetiapine has equivalent efficacy and superior tolerability to risperidone in the treatment of schizophrenia with predominantly negative symptoms. Eur Arch Psychiatry Clin Neurosci 255:432-437
33. Robbins TW (1990) The case for frontostriatal dysfunction in schizophrenia. Schizophr Bull 16(3):391-402
34. Scheuerecker J, Ufer S, Frodl T, Koutsouleris N, Zipse M, Zetzsche T, Wiesmann M, Albrecht J, Schmitt G, Müller HJ, Meisenzahl EM (2006) Cerebral changes and cognitive dysfunctions in medication-free schizophrenia-an fMRI study. J Psychiatr Res (1st revision)
35. Schlosser R, Gesierich T, Kaufmann B, Vucurevic G, Hunsche S, Gawehn J, Stoeter P (2003) Altered effective connectivity during working memory performance in schizophrenia: a study with fMRI and structural equation modeling. Neuroimage 19(3):751-763
36. Schmahmann JD, Sherman JC (1997) Cerebellar cognitive affective syndrome. Int rev Neurbiol 41:433-440
37. Sharma T (2001) Quetiapine-efficacy in different domains. Eur Neuropsychopharmacol 11(4):385-390
38. Stern CE, Owen AM, Tracey I, Look RB, Rosen BR, Petrides M (2000) Activity in ventrolateral and mid-dorsolateral prefrontal cortex during nonspatial visual working memory processing: evidence from functional magnetic resonance imaging. Neuroimage 11(5):392-399
39. Stip E, Fahim C, Mancini-Marie A, Bentaleb LA, Mensour B, Mendrek A, Beauregard M (2005) Restoration of frontal activation during a treatment with quetiapine: a fMRI study of blunted affect in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 29(1):21-26
40. Velligan DJ, Newcomer J, Pultz J, Csernansky J, Hoff AL, Mahurin R, Miller AL (2002) Does cognitive function improve with quetiapine in comparison to haloperidol? Schizophr Res (53):239-248
41. Weickert TW, Goldberg TE, Marenco S, Bigelow LB, Egan MF, Weinberger DR (2003) Comparison of cognitive performances during a placebo period and an atypical antipsychotic treatment period in schizophrenia: critical examination of confounds. Neuropsychopharmacology 28(8):1491-1500
42. Weinberger DR, Berman KF (1996) Prefrontal function in schizophrenia: confounds and controversies. Philos Trans R Soc Lond B Biol Sci 351(1346):1495-503